The 1997 asthma guidelines and an asthma clinical update

American Journal of Managed Care

Volumn 6, Issue 7 SUPPL., 2000, Pages

  Stoloff, Stuart W ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE; TRIAMCINOLONE;

ALLERGENICITY; ASTHMA; CLINICAL PHARMACOLOGY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FUNCTIONAL ASSESSMENT; HEALTH CARE; HUMAN; OUTCOMES RESEARCH; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0033997440     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Centers for Disease Control and Prevention. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb Mortal Wkly Rep 1998;47:1022-1025.
2. Centers for Disease Control and Prevention. Surveillance for Asthma - United States, 1960-1995. MMWR Morb Mortal Wkly Rep 1998;47(No. SS-1)1-27.
3. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
4. National Institutes of Health, National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. Publication 97-4051.
5. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993;329: 1271-1273.
6. Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the National Institutes of Health Consensus Development Program on physician practice. JAMA 1987;258:2708-2713.
7. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-1311.
8. Nguyen BP, Wilson SR, German DF. Patients' perceptions compared with objective ratings of asthma severity. Ann Allergy Asthma Immunol 1996;77:209-215.
9. Grunfeld AF, Ho K. Emergency management of acute adult asthma. Can Fam Physician 1995;41:1909-1916.
10. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK. Asthma in the elderly: Underperceived, underdiagnosed and undertreated: A community survey. Respir Med 1998;92:573-577.
11. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: Patients treated in general practice. BMJ 1993;307:422-424.
12. Russell NJ, Crichton NJ, Emerson PA, Morgan AD. Quantitative assessment of the value of spirometry. Thorax 1986;41:360-363.
13. National Institutes of Health, National Heart, Lung, and Blood Institute, World Health Organization. Global Strategy -Global Initiative for Asthma. National Heart, Lung, and Blood Institute/World Health Organization Workshop Report. Bethesda, MD: National Institutes of Health; 1995. Publication 96-3659A.
14. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52(suppl 39):1-34.
15. Bisgaard H. Use of inhaled corticosteroids in pediatric asthma. Pediatr Pulmonary Supplement 1997;15:27-33.
16. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
17. Condemi JJ, Chervinsky P, Goldstein MF, et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997;100:467-474.
18. Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt WR. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma. J Allergy Clin Immunol 1999;103:796-803.
19. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234.
20. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-891.
21. Szefler SJ, Boushey HA, Pearlman DS, et al. Time to onset of effect of fluticasone propionate in patients with asthma. J Allergy Clin Immunol 1999;103:780-788.
22. Allen DB, Bronsky EA, LaForce CF, et al. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr 1998;132:472-477.
23. Li JT, Ford LB, Chervinsky P, et al. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol 1999;103:1062-1068.
24. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al, for the Montelukast/ Beclomethasone Study Group. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized controlled trial. Ann Intern Med 1999; 130:487-495.
25. Greening AP, Ind PW, Northfield M, Shaw G, for the Allen & Hanburys Limited UK Study Group. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
26. Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. J Allergy Clin Immunol 1999;103:1075-1080.